drugset / Trial / NCT00272103

Itopride in Functional Dyspepsia:a Dose Finding Study

NCT00272103

RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to determine the efficacy and optimal dose of the prokinetic itopride for the treatment of patients with functional dyspepsia. The study will test in patients with functional dyspepsia the hypothesis that itopride is superior to placebo with regard to the improvement of symptoms.

Timeline

Start
2000-12
Primary completion
Completion
2002-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Itopride Small molecule 50 mg
Subject Itopride Small molecule 100 mg
Subject Itopride Small molecule 200 mg

Indications